Validation of Anaphylaxis in the Food and Drug Administration's Mini-Sentinel

Project Title Validation of Anaphylaxis in the Food and Drug Administration's Mini-Sentinel
Date
Thursday, September 5, 2013
Location

Pharmacoepidemiology and Drug Safety, Volume 22, Issue 11, November 2013, Pages 1205–1213, DOI: 10.1002/pds.3505

Description

This article describes a Mini-Sentinel project to validate an algorithm based on International Classification of Diseases, Ninth revision, Clinical Modification (ICD-9-CM) codes for anaphylaxis among health plan members in the Mini-Sentinel Distributed Database (MSDD) using medical record review.

Health Outcome
anaphylaxis
Time Period
2009-2010
Corresponding Author

K. Walsh, University of Massachusetts, 55 Lake Avenue North, Worcester, MA, 01655, Email: Kathleen.Walsh2@umassmemorial.org. Moved to: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, Email: Kathleen.Walsh@cchmc.org

Authors

Kathleen Walsh MD, MSc; Sarah Cutrona MD, MPH; Sarah Foy BA; Meghan Baker MD, ScD; Susan Forrow BA; Azadeh Shoaibi PhD, MHS, MS; Pamala Pawloski PharmD; Michelle Conroy MD; Andrew Fine MD, MPH; Lise Nigrovic MD, MPH; Nandini Selvam PhD, MPH; Mano Selvan PhD; William Cooper MD, MPH; Susan Andrade ScD

Data Sources
Mini-Sentinel Distributed Database (MSDD)
Related Assessments
Validation of Anaphylaxis Cases
Publication Type
Publication
Scroll to Top